Rodger, Novak, M.D.

Rodger, Novak, M.D.

Former President and ChairmanatCRISPR Therapeutics AG· In proxies 2022–2023

Pay in FY2023+192% from the year before · CRISPR Therapeutics AG stock +54.0% the same year

Rodger, Novak, M.D. was paid $555.1K in FY2023 (Dec), up 192%. CRISPR Therapeutics AG stock rose 54.0% that year.

Pay$100 in the stock at the end of FY21 → $83
Pay is from the Summary Compensation Table of each CRISPR Therapeutics AG proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

  1. CRISPR Therapeutics AGPublic company · 4 yr
    • Former President and Chairman2022 – Present · 4 yrStock in role -30%

Roles come from the proxy statements of each company.

Activity

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?